Atrium Health President and CEO Eugene Woods, who now will serve as president and CEO of the newly merged health system, said the merged organization aims "to build a 'Silicon Valley' for health care innovation spanning from Winston-Salem to Charlotte," in today's bite-sized hospital and health industry news from California, North Carolina, and Ohio.
Johnson & Johnson on Monday announced that it has paused dosing in all of its clinical trials on its experimental coronavirus vaccine to investigate an "unexplained illness in a study participant." Separately, NIH on Tuesday announced that it has paused a clinical trial on Eli Lilly's experimental coronavirus treatment due to potential safety issues.
Advisory Board's Prianca Pai sat down with Joseph Gannett, a resident at University Medical Center New Orleans, who explained how language barriers can prevent meaningful communication between clinicians and patients, which compromises quality of care, patients' trust in the health system, and staff morale.
Covid-19 accelerated digital health in unprecedented ways, forcing health systems to examine their digital health strategy. In this Radio Advisory excerpt, host Rachel Woods sits down with Advisory Board's John League and Andrew Rebhan to talk about how providers should react to recent deals in the digital health space—including Teladoc's acquisition of Livongo—and what the future of digital health will look like.
Scientists say they've discovered that a 25-year-old man in Nevada was infected with the novel coronavirus twice—marking the first confirmed case of coronavirus reinfection in the country—and that the symptoms of his second infection were more severe than the first, according to a case study published Monday in The Lancet.
Print All Daily Briefing Article from
10/14/2020
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
